The OSUCCC – James clinical lymphoma research program team members include world-renowned specialists and sub-specialists in the prevention, diagnosis, genetic sequencing and treatment of lymphoma and blood-related diseases. This team comprises talented experts who work to seamlessly translate research to the clinic.
Lymphoma Research
Who We Are
The internationally renowned experts in the OSUCCC – James lymphoma research program are dedicated to developing and conducting basic, translational, clinical and outcome-based research that advances innovative breakthroughs and treatments for patients with lymphoid malignancies.
Lymphoma Clinical Research Faculty
I am a board-certified hematologist who specializes in treating cancers that are centered in the lymph nodes.
I am a medical oncologist who treats patients with blood cancers.
I’m a hematologist-oncologist and provide clinical, inpatient care of patients with acute myeloid leukemia and acute lymphocytic leukemia.
I am a hematologist who specializes in treating patients with Hodgkin’s and non-Hodgkin’s lymphoma.
I’m a hematologist specializing in patients with T-cell lymphoma, T-cell leukemia, non-Hodgkin lymphoma, and allogenic and autologous stem cell transplantation.
Wing Keung Chan, PhD
I am a hematologist and oncologist who specializes in treating patients with aggressive and indolent B-cell non-Hodgkin’s and Hodgkin’s lymphoma.
I am a hematologist who specializes in the treatment of malignant blood cancers, specifically lymphomas.
I am an associate professor in the Division of Hematology at The Ohio State University and a member of the Leukemia and Hematologic Malignancies Program at the OSUCCC – James, where my research focuses on innate and adaptive immune responses in viral infections and cancer.
I am a hematologist who specializes in treating patients with B-cell malignancies, such as non-Hodgkin’s lymphoma (NHL), Hodgkin’s lymphoma (HD) and chronic lymphocytic leukemia (CLL).
I am a member of the Leukemia and Hematologic Malignancies Program at the OSUCCC – James, where my research focuses on several areas, including biological therapies for hematologic malignancies, the development and characterization of clinically relevant animal models of lymphoid malignancies and targeted delivery of RNA-based therapeutics in lymphoid and myeloid malignancies.
As a member of the Leukemia and Hematologic Malignancies Program at the OSUCCC – James, I focus on investigating and understanding the role of epigenetics in normal development and carcinogenesis.
I am a hematologist who specializes in treating patients with lymphoma.
I am a hematologist who specializes in the treatment of lymphomas, particularly indolent and aggressive B-cell non-Hodgkin’s lymphoma and Hodgkin’s lymphoma.
I am a translational scientist and an assistant professor in the Division of Hematology at The Ohio State University.
I am a hematologist who specializes in treating patients with B-cell malignancies, including non-Hodgkin lymphoma and Hodgkin lymphoma.
My research focuses on genomics, transcriptional and epigenomic regulation in cancer and cancer immunology, therapeutic efficacy of new drugs with patients-derived xenograft (PDX) mouse model, screening and function analysis of the genetic defects in human hematologic malignancies, and also the immune escape mechanism in cancer particularly the transcriptional regulation of PD-L1 and 3D chromosome structure of regulatory T (Treg) cells and its roles in cancer.
I am an assistant professor in the Division of Hematology at The Ohio State University and a member of the Translational Therapeutics Program at the OSUCCC —– James.
I am a nationally recognized expert in cancer immunology and immunotherapy who serves as the director of the Division of Hematology at The Ohio State University.